Bridgewater Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,471
| Closed | -$252K | – | 700 |
|
|
2024
Q3 | $252K | Sell |
10,471
-5,663
| -35% | -$136K | ﹤0.01% | 754 |
|
|
2024
Q2 | $321K | Sell |
16,134
-1,127
| -7% | -$22.5K | ﹤0.01% | 810 |
|
|
2024
Q1 | $344K | Sell |
17,261
-15,529
| -47% | -$309K | ﹤0.01% | 649 |
|
|
2023
Q4 | $735K | Sell |
32,790
-21,584
| -40% | -$484K | ﹤0.01% | 672 |
|
|
2023
Q3 | $1.1M | Buy |
54,374
+4,516
| +9% | +$91.3K | 0.01% | 591 |
|
|
2023
Q2 | $1.27M | Sell |
49,858
-6,381
| -11% | -$163K | 0.01% | 543 |
|
|
2023
Q1 | $1.67M | Buy |
56,239
+1,974
| +4% | +$58.7K | 0.01% | 488 |
|
|
2022
Q4 | $1.47M | Sell |
54,265
-18,638
| -26% | -$504K | 0.01% | 583 |
|
|
2022
Q3 | $1.59M | Sell |
72,903
-1,306
| -2% | -$28.4K | 0.01% | 607 |
|
|
2022
Q2 | $2.03M | Buy |
74,209
+6,640
| +10% | +$182K | 0.01% | 683 |
|
|
2022
Q1 | $2.26M | Buy |
67,569
+14,618
| +28% | +$490K | 0.01% | 655 |
|
|
2021
Q4 | $1.84M | Buy |
52,951
+5,735
| +12% | +$199K | 0.01% | 475 |
|
|
2021
Q3 | $1.47M | Sell |
47,216
-2,422
| -5% | -$75.6K | 0.01% | 473 |
|
|
2021
Q2 | $1.81M | Buy |
+49,638
| New | +$1.81M | 0.01% | 509 |
|